Chemprop

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

LangChain is a framework for developing applications powered by large language models (LLMs). It simplifies every stage of the LLM application lifecycle, including development, productionization, and deployment. LangChain consists of open-source libraries such as langchain-core, langchain-community, and partner packages. It also includes LangGraph for building stateful agents and LangSmith for debugging and monitoring LLM applications.

Predibase is a platform for fine-tuning and serving Large Language Models (LLMs). It provides a cost-effective and efficient way to train and deploy LLMs for a variety of tasks, including classification, information extraction, customer sentiment analysis, customer support, code generation, and named entity recognition. Predibase is built on proven open-source technology, including LoRAX, Ludwig, and Horovod.

Unify is an AI tool that offers a unified platform for accessing and comparing various Language Models (LLMs) from different providers. It allows users to combine models for faster, cheaper, and better responses, optimizing for quality, speed, and cost-efficiency. Unify simplifies the complex task of selecting the best LLM by providing transparent benchmarks, personalized routing, and performance optimization tools.

Imandra is a company that provides automated logical reasoning for Large Language Models (LLMs). Imandra's technology allows LLMs to build mental models and reason about them, unlocking the potential of generative AI for industries where correctness and compliance matter. Imandra's platform is used by leading financial firms, the US Air Force, and DARPA.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

Kubeflow is an open-source machine learning (ML) toolkit that makes deploying ML workflows on Kubernetes simple, portable, and scalable. It provides a unified interface for model training, serving, and hyperparameter tuning, and supports a variety of popular ML frameworks including PyTorch, TensorFlow, and XGBoost. Kubeflow is designed to be used with Kubernetes, a container orchestration system that automates the deployment, management, and scaling of containerized applications.

NLTK (Natural Language Toolkit) is a leading platform for building Python programs to work with human language data. It provides easy-to-use interfaces to over 50 corpora and lexical resources such as WordNet, along with a suite of text processing libraries for classification, tokenization, stemming, tagging, parsing, and semantic reasoning, wrappers for industrial-strength NLP libraries, and an active discussion forum. Thanks to a hands-on guide introducing programming fundamentals alongside topics in computational linguistics, plus comprehensive API documentation, NLTK is suitable for linguists, engineers, students, educators, researchers, and industry users alike.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

AppTek is a global leader in artificial intelligence (AI) and machine learning (ML) technologies for automatic speech recognition (ASR), neural machine translation (NMT), natural language processing/understanding (NLP/U) and text-to-speech (TTS) technologies. The AppTek platform delivers industry-leading solutions for organizations across a breadth of global markets such as media and entertainment, call centers, government, enterprise business, and more. Built by scientists and research engineers who are recognized among the best in the world, AppTek’s solutions cover a wide array of languages/ dialects, channels, domains and demographics.

PolygrAI is a digital polygraph powered by AI technology that provides real-time risk assessment and sentiment analysis. The platform meticulously analyzes facial micro-expressions, body language, vocal attributes, and linguistic cues to detect behavioral fluctuations and signs of deception. By combining well-established psychology practices with advanced AI and computer vision detection, PolygrAI offers users actionable insights for decision-making processes across various applications.

LlamaIndex is a framework for building context-augmented Large Language Model (LLM) applications. It provides tools to ingest and process data, implement complex query workflows, and build applications like question-answering chatbots, document understanding systems, and autonomous agents. LlamaIndex enables context augmentation by combining LLMs with private or domain-specific data, offering tools for data connectors, data indexes, engines for natural language access, chat engines, agents, and observability/evaluation integrations. It caters to users of all levels, from beginners to advanced developers, and is available in Python and Typescript.

SOMA is a Research Automation Platform designed to accelerate medical innovation by automating the process of analyzing medical research articles. It extracts important concepts, identifies causal and associative relationships, and organizes information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like drug repurposing, target discovery, and literature review efficiently. The platform offers API access, community support, and freemium sign-up options.

NuMind is an AI tool designed to solve information extraction tasks efficiently. It offers high-quality lightweight models tailored to users' needs, automating classification, entity recognition, and structured extraction. The tool is powered by task-specific and domain-agnostic foundation models, outperforming GPT-4 and similar models. NuMind provides solutions for various industries such as insurance and healthcare, ensuring privacy, cost-effectiveness, and faster NLP projects.

Yseop offers Natural Language Generation (NLG) services that automate and translate data into actionable language, simplifying complex workflows. Its AI-based technologies generate core elements of specialist medical reports, including clinical study reports (CSR), patient narratives, and more. Yseop also automates the writing of financial reports, removing the risk of error in manual writing to ensure accuracy, consistency, and compliance. Additionally, Yseop provides bespoke NLG applications tailored to specific needs, helping streamline operations and empower workers with tailored information and insights.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

SceneDreamer is an AI tool that learns to generate unbounded 3D scenes from in-the-wild 2D image collections. It synthesizes diverse landscapes with 3D consistency, well-defined depth, and free camera trajectory. The framework comprises an efficient 3D scene representation, generative scene parameterization, and a neural volumetric renderer. SceneDreamer excels in generating vivid and diverse unbounded 3D worlds without the need for 3D annotations.

fast.ai is an AI tool that offers courses and resources on deep learning and practical applications of artificial intelligence. The platform provides high-level components for practitioners to achieve state-of-the-art results in standard deep learning tasks. It aims to increase diversity in the field of deep learning and lower barriers to entry for everyone.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that aims to accelerate drug development by providing accurate crystal structure predictions for small molecule drugs. The application helps in de-risking pipelines, optimizing solid-state formulations, and avoiding late-stage surprises through cutting-edge AI technology. Lavo Life Sciences combines expertise in AI and computational chemistry to offer fast and efficient solutions for drug development teams, enabling them to discover novel polymorphs and make informed decisions to enhance drug development processes.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Rationale is a cutting-edge decision-making AI tool that leverages the power of the latest GPT technology and in-context learning. It is designed to assist users in making informed decisions by providing valuable insights and recommendations based on data analysis and machine learning algorithms.

Formula Wizard is an AI-powered software designed to assist users in writing Excel, Airtable, and Notion formulas effortlessly. By leveraging artificial intelligence, the application automates the process of formula creation, allowing users to save time and focus on more critical tasks. With features like automating tedious tasks, unlocking insights from data, and customizing templates, Formula Wizard streamlines the formula-writing process for various spreadsheet applications.

Lintas88 is a trusted and top-rated online Toto and Togel site that offers a variety of exciting and profitable online lottery games. Known for its transparent and secure gaming system, Lintas88 allows players to bet on various types of lottery games such as 4D, 3D, 2D, Colok Bebas, Colok Naga, and more. With years of experience in the online gambling industry, Lintas88 has built a reputation as a trusted Toto site that players from around the world can rely on.